Cargando…
Initial dip predicts renal protective effects after the administration of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and chronic kidney disease with normoalbuminuria
INTRODUCTION: We investigated the renoprotective effects of sodium-glucose cotransporter 2 inhibitors (SGLT2is) on renal function in patients with type 2 diabetes and chronic kidney disease (CKD) with normoalbuminuria. METHODS: A retrospective review of clinical records of Japanese participants with...
Autores principales: | Takahashi, Kiyohiko, Nakamura, Akinobu, Furusawa, Sho, Yokozeki, Kei, Sugawara, Hajime, Yanagisawa, Hideyuki, Akikawa, Kazumasa, Kikuchi, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726333/ https://www.ncbi.nlm.nih.gov/pubmed/33318949 http://dx.doi.org/10.1016/j.jcte.2020.100244 |
Ejemplares similares
-
Impact of sodium–glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria
por: Nakamura, Akinobu, et al.
Publicado: (2020) -
The Ratio of Glycosylated Albumin to Glycosylated Hemoglobin Differs Between Type 2 Diabetic Patients With Low Normoalbuminuria and Those With High Normoalbuminuria or Microalbuminuria
por: Katahira, Masahito, et al.
Publicado: (2013) -
Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages
por: Takahashi, Kiyohiko, et al.
Publicado: (2018) -
Predictors of Diabetic Retinopathy in Patients with Type 2 Diabetes Who Have Normoalbuminuria
por: Karoli, R, et al.
Publicado: (2013) -
Clinical Implications of Estimated Glomerular Filtration Rate Dip Following Sodium‐Glucose Cotransporter‐2 Inhibitor Initiation on Cardiovascular and Kidney Outcomes
por: Xie, Yan, et al.
Publicado: (2021)